| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8736 |
| Human Intestinal Absorption | HIA+ | 0.9832 |
| Caco-2 Permeability | Caco2+ | 0.8629 |
| P-glycoprotein Substrate | Non-substrate | 0.6744 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6684 |
| Non-inhibitor | 0.6287 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8418 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7823 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7523 |
| CYP450 2D6 Substrate | Non-substrate | 0.7857 |
| CYP450 3A4 Substrate | Non-substrate | 0.6383 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5507 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8880 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8828 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5425 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8310 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5110 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8355 |
| Non-inhibitor | 0.9279 |
| AMES Toxicity | Non AMES toxic | 0.9265 |
| Carcinogens | Non-carcinogens | 0.8432 |
| Fish Toxicity | High FHMT | 0.9431 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9663 |
| Honey Bee Toxicity | High HBT | 0.8095 |
| Biodegradation | Not ready biodegradable | 0.6080 |
| Acute Oral Toxicity | III | 0.8605 |
| Carcinogenicity (Three-class) | Non-required | 0.5959 |